Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Impact of Eyelid Filler Injections on Lower Blepharoplasty to Correct Under Eye Bags
  • USA - English


News provided by

Goldman Marketing Group

Jun 13, 2017, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Beverly Hills Oculoplastic Surgeon Dr. Mehryar (Ray) Taban
Beverly Hills Oculoplastic Surgeon Dr. Mehryar (Ray) Taban

"More comprehensive research is needed, but the initial results show that a ‘revision’ lower blepharoplasty delivers impressive results," said Dr. Taban

Post this

Beverly Hills, CA (PRWEB) June 13, 2017 -- In cosmetic dermatology, eyelid fillers made of a cross-linked hyaluronic acid gel are widely used because they are effective at improving under eye bags, among other skin concerns, yet many patients have unsatisfactory results, such as a “residual fullness” that can include fat, scar tissue, or undissolved filler substance. However, this “residual fullness” could actually just be a puffy lower eyelid, which can be corrected with a lower blepharoplasty. Curious to learn what kind of impact a previous dermal filler treatment would have on this type of surgery, oculoplastic surgeon Dr. Mehryar (Ray) Taban conducted a three-year study that ended in December 2015. The initial findings, recently presented by Dr. Taban at the Vegas Cosmetic Conference in Las Vegas as well as published in the American Journal of Cosmetic Surgery, are important for other oculoplastic surgeons to consider.

“Eyelid fillers with hydrating hyaluronic acid gel are effective for improving under eye bags or orbital fat prolapse,” explained Dr. Taban, “but there are also limitations, including the relatively short duration of the effects and subsequent, though slight, anatomical changes. Plus, the previous injector may have injected too much gel or injected the filler in the wrong location; or perhaps the wrong diagnosis was made, which means the patient may have been better served by undergoing a lower eyelid surgery in the first place. Although unsatisfactory filler results can be removed with hyaluronidase injections, a patient is still left with a cosmetic under eye concern that still needs correcting.”

In the study, Dr. Taban performed a lower blepharoplasty on patients who have had unsatisfactory results from previous hyaluronic acid dermal filler injections. If a patient had any eyelid filler residue remaining, it was removed with injections of hyaluronidase. In spite of the fact that the study was small, Dr. Taban was intrigued by the results.

“We found that, although some of the soft tissue around the lower eye actually became softer—more spongy, if you will—the results were aesthetically pleasing,” Dr. Taban said. “The puffiness in the lower eyelid and the appearance of the under eye bags were improved and there was a very high rate of satisfaction among the patients. What we also found is that due to the anatomical changes from a filler injection, this surgery might be more properly termed a ‘revision’ lower blepharoplasty.”

For patients who have previously been treated with hyaluronic acid eyelid fillers, the results of Dr. Taban’s study are promising. Though more research is necessary, early indications are that a “revision” lower blepharoplasty (with fat repositioning) is safe and effective for addressing issues with “residual fullness” that may or may not be a side effect of the previous eyelid filler treatment. To learn more about this study, or to learn more about cosmetic eye surgery in general, visit http://TabanMD.com/Aesthetic-Cosmetic/

“Though the results are impressive, the study had limitations, such as the small number of patients and the fact that they were not chosen randomly,” added Dr. Taban. “Furthermore, each patient received their previous eyelid filler injections from a different injector, meaning there’s no guarantee of consistency in injector training, skills, or technique. More comprehensive research is needed, but the initial results show that a ‘revision’ lower blepharoplasty delivers impressive results with no post-op complications or repeat procedures.”

Meet Dr. Taban: http://TabanMD.com/About-Oculoplastic-Surgeon/

Mehryar (Ray) Taban, MD is a Santa Barbara and Beverly Hills, Los Angeles oculoplastic surgeon (cosmetic and reconstructive eyelid plastic surgery) who is committed to his patients’ progress and results. He offers an array of reconstructive and cosmetic procedures, with a focus on the face in general and the eyes in particular. He has had extensive training and is triple board-certified by the American Society of Oculofacial Plastic Surgery (ASOPRS), American Board of Cosmetic Surgery (ABCS) and American Board of Ophthalmology (ABO). Due to Dr. Mehryar (Ray) Taban's expertise in eye plastic surgery, he is often called upon to help other physicians with their complex cases, and frequently publishes articles and lectures to physicians around the country.

For more information on Dr. Taban and his services, please visit http://www.TabanMD.com.

Dr. Mehryar (Ray) Taban, MD
9735 Wilshire Boulevard #319
Beverly Hills, CA 90212
(877) 958-9277
DrTabanInquiry (at) gmail (dot) com

Risa Goldman, Goldman Marketing Group, +1 818-861-7092, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.